Top 5 Medical Device Startup Investors in Russian Federation in April 2025

Last updated: Apr 2025 A list of 5 angel investors and VC (Venture Capital) funds that invest in Medical device startups based in Russian federation. We rank investors based on the number of investments they made in Medical device companies from Russian federation. We update this investor list every month.

Top 5 Medical Device Startup Investors in Russian Federation in April 2025

Investor	Medical Device Russian Federation investments
Moscow Seed Fund	2
Russian Direct Investment Fund	2
Human stem cells institute PJSC	1
FASIE	1
TealTech Capital	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

The Fund for the Promotion of Venture Investment in Small Enterprises in the Scientific and Technical Sphere of Moscow was established by the Department of Entrepreneurship and Innovation Policy of Moscow.

Investment focus

Software, Advertising, Information Technology
Seed, Debt Financing, Funding Round
Russian Federation, United States, Israel

Portfolio highlights

Vestem — Vestem is a biotechnology company that develops new bioveterinary cell therapies for regenerative therapy and next-generation pharmaceuticals for the treatment of pets.
Picvario — DAM systems allow centralizing, systematizing, searching, and sharing all types of digital files (images, video, audio, etc.). Picvario platform is a reliable storage of the files. Flexible management. API Integration
Qummy — Qummy produces and freezes dishes for restaurants using its patented Smart Ice technology, which preserves the dish's nutritional and organoleptic features.

Russian Direct Investment Fund is a Russia’s sovereign wealth fund with reserved capital of $10 billion under management. Working alongside the world’s foremost investors, we make direct investments in leading, as well as promising, Russian companies. RDIF attracted over $40 billion of foreign capital into the Russian economy through long-termstrategic partnerships

Investment focus

Transportation, Logistics, Software
Funding Round, Private Equity, Series A
Russian Federation, United States, China

Portfolio highlights

Borzo — Borzo is a global delivery service that enables intracity same-day delivery. Our algorithms optimize numerous parallel deliveries taking into account the geographical routes, packages’ contents, couriers and many others to ensure the feasibility of the same-day delivery. The services are available in 10 countries including Brazil, India, Indonesia,Korea, Malaysia, Mexico, the Philippines, Russia, Turkey and Vietnam and are used by 3 million customers ranging from SMEs to enterprises.
IXcellerate — IXcellerate is an unparalleled Carrier Neutral Data Centre in Moscow, which is comparable to the quality of data centres in America and Western Europe. IXcellerate offers pure-play co-location designed to meet the standards of financial institutions, MNCs, international carriers and major content operators. IXcellerate provides clients with abespoke solution aimed towards solving their unique requirements. Located within the MKAD of Central Moscow, IXcellerate Datacenter can provide basic co-location or private and secure cages. As a carrier-neutral facility, affordable and resilient connectivity will be available within Moscow, Russia and the entire World.
Quassar Capital — Quassar Capital is a hedge fund with a broad presence in the United States with offices in New York and London. We are widely respected for our asset management approach globally but more importantly for our innovative operating methodology that allows us to maintain exceptional management of advanc

Human Stem Cell Institute (PJSC "HSCI") - a Russian public company founded in 2003 and works in the field of modern biomedical technology and health care. HSCI develops and implements in medical practice (commercialization and promotion of the market), innovative medicines, as well as high-tech medical services.

Investment focus

Medical, Genetics, Biotechnology
Seed
Russian Federation

Portfolio highlights

Histograft — Histograft is a bio-medical manufacturer of gene-activated osteoplastic material intended for bone grafting in surgical dentistry & surgery.

Foundation’s main tasks include the implementation of government policy for the development and support of small innovative enterprises (SME); offering direct financial, informational and other aid to small innovative enterprises, implementation of projects to develop and produce new high-tech products; and creating and developing an infrastructurefor SME.